Publicacións en colaboración con investigadores/as de Sahlgrenska University Hospital (2)

2024

  1. A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels

    Upsala journal of medical sciences, Vol. 129

2023

  1. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

    Cardiovascular Drugs and Therapy, Vol. 37, Núm. 5, pp. 941-953